Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Success
Alert
Please select a Day.
Info

AstraZeneca Pharma Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE

74/100
8,869.00
68.50 (0.78%)

As on 25 Feb, 2026 | 03:52

Open Trading A/c
Day Range
8771.00
8889.00
L H
52 Week Range
3695.15
10691.00
L H
Volume
2,566
*
i

* BSE Market Depth (25 Feb 2026)

BUY SELL
QTY PRICE PRICE QTY
2 8787.00 8900.00 1
1 8780.00 8920.00 1
2 8710.00 8990.60 1
1 8701.00 9311.00 10
5 8668.00 9450.00 1
0 Total Total 0
Bid / Ask
8710.00 / 8920.00
74/100
8,820.65
29.30 (0.33%)

As on 25 Feb, 2026 | 04:01

Open Trading A/c
Day Range
8709.00
8868.75
L H
52 Week Range
6501.60
10653.05
L H
Volume
49
*
i

* BSE Market Depth (25 Feb 2026)

BUY SELL
QTY PRICE PRICE QTY
2 8787.00 8900.00 1
1 8780.00 8920.00 1
2 8710.00 8990.60 1
1 8701.00 9311.00 10
5 8668.00 9450.00 1
0 Total Total 0
Bid / Ask
8710.00 / 8920.00
NSE
MC Essentials
71% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 8,771.00
          Previous Close 8,800.50
          Volume 2,566.00
          Value (Lacs) 227.58
            VWAP 0.00
          Beta
          Mkt Cap (Rs. Cr.) 22,173
          High 8,889.00
          Low 8,771.00
          UC Limit 0.00
          LC Limit 0.00
          52 Week High 10,691.00
          52 Week Low 3,695.15
          Face Value 2.00
          All Time High 10,691.00
          All Time Low 32.60
          20D Avg Volume 7,222
          20D Avg Delivery(%) 40.89
          Book Value Per Share --
          Dividend Yield 0.36
          TTM EPS See historical trend 0.00 (+107.18% YoY)
          TTM PE See historical trend -- (Average PE)
          P/B See historical trend 0.00 (High P/B)
          Sector PE 40.09

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          74/100
          Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 17.04% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 75.00% in Dec 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          CHART PATTERNS Super PRO

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          13 out of 18 years AstraZeneca Pharma has given negative returns in February.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          February 26.64% (2019) 14.85% -30.01% (2013) -7.92% -1.59%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying AstraZeneca

          What's your call on AstraZeneca today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          07 Oct, 2024

          Graviton Research Capital Llp

          Qty 125166 Price 7884.41 % Traded 0.50
          07 Oct, 2024

          Graviton Research Capital Llp

          Qty 125166 Price 7887.16 % Traded 0.50
          30 Sep, 2024

          Graviton Research Capital Llp

          Qty 127119 Price 7804.96 % Traded 0.50
          30 Sep, 2024

          Graviton Research Capital Llp

          Qty 127119 Price 7802 % Traded 0.50
          24 Sep, 2024

          Graviton Research Capital Llp

          Qty 131308 Price 7499.17 % Traded 0.50
          24 Sep, 2024

          Graviton Research Capital Llp

          Qty 131308 Price 7506.36 % Traded 0.50

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          About the Company

          Astrazeneca Pharma India Ltd (AZPIL) is engaged in the business of manufacturing and marketing pharmaceutical products in healthcare segments namely gastrointestinal, cardiovascular, cancer, respiratory, neurosciences and infection. The company manufactures a wide variety of products under each of it`s segment which include the following Cardiovascular- Under this segment company manufactures and markets products namely Betaloc, Seloken XL, Imdur, Ramace and Plendil and many more,Respiratory-Company develops drugs such as Rhinocort, Mits Linctus, Bricarex, Bricanyl, etc.,Maternal Healthcare- Under this segment, company produces Prostodin, Cerviprime, Primiprost, Partocin and many more.,Oncology-Company manufactures products such as Zoladex & Arimidex, Nolvadex and Iressa & Casodex under oncology segment,Infection-Company develops products such as Meronem and Vancocin CP and many more&Pain Control and Anaesthesia- Company offers products such as Xylocaine and Sensorcaine.The company plans to continue to invest in all focussed brands and on business development so as to increase sales and profitability and consequently increase stakeholder value..The company also engagged in the business of Healthcare.
          {"success":1,"data":{"address":{"address1":"Block N1, 12th Floor, \n\n","address2":"Manyata Embassy Business Park, \n,\nRachenahalli, Outer Ring Road,","city":"Bengaluru","state":"Karnataka","pincode":"560045","telephone1":"080-67748000","telephone2":"","fax1":"080-67748557","fax2":"","email":"comp.secy@astrazeneca.com","web":"http:\/\/www.astrazeneca.com\/india"},"management":[{"name":"Shilpa Divekar Nirula","designation":"Chairperson & Independent Director"},{"name":"Praveen Rao Akkinepally","designation":"Managing Director"},{"name":"Bhavana Agrawal","designation":"Executive Director"},{"name":"Sylvia Lorena Varela Ramon","designation":"Non Executive Director"},{"name":"Hooi Bien Chuah","designation":"Non Executive Director"}],"registrars":{"name":"Integrated Registry Management Services Pvt. Ltd.","address1":"#30, Ramana Residency, 4th Cross,\nSampige Road, Ma","address2":"","address3":"","address4":"","telephone":"080-23460815-818","fax":"080-23460819","email":"irg@integratedindia.in","internet":"https:\/\/www.integratedindia.in","city":"Bengaluru","state":"Karnataka","pincode":"560003"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"506820","nseId":"ASTRAZEN","series":"EQ","isinid":"INE203A01020"}}}
          • Registered Office

          • Registrars

          • Management

            • Shilpa Divekar Nirula

              Chairperson & Independent Director

            • Praveen Rao Akkinepally

              Managing Director

            • Bhavana Agrawal

              Executive Director

            • Sylvia Lorena Varela Ramon

              Non Executive Director

            • Hooi Bien Chuah

              Non Executive Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              No

          • Details

            • BSE:

              506820

            • NSE:

              ASTRAZEN

            • Series

              EQ

            • ISIN

              INE203A01020

          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
          Close Parallel Income Plan 2026